Athersys (ATHX) News Today Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 1:25 AM | americanbankingnews.comAthersys (NASDAQ:ATHX) Coverage Initiated by Analysts at StockNews.comApril 24, 2024 | finance.yahoo.comAthersys, Inc. (ATHXQ)April 8, 2024 | bizjournals.comBankruptcy of once-promising Athersys winding down with assets saleFebruary 26, 2024 | investing.comToughbuilt Industries Inc (TBLT)February 17, 2024 | morningstar.comAthersys Inc ATHXQJanuary 8, 2024 | marketwatch.comAthersys to Sell Most Assets to HealiosNovember 16, 2023 | finance.yahoo.comAthersys Reports Third Quarter 2023 Financial Results and Business HighlightsOctober 23, 2023 | bizjournals.comAthersys shares migrate to Pink marketplace for broker-to-broker tradingOctober 20, 2023 | bizjournals.comAthersys shares delisted by Nasdaq Stock MarketOctober 16, 2023 | finance.yahoo.comAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesOctober 10, 2023 | msn.comAthersys crashes after bankruptcy warningOctober 10, 2023 | finance.yahoo.comAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosOctober 10, 2023 | marketbeat.comTrading was temporarily halted for "ATHX" at 08:10 AM with a stated reason of "News pending."October 3, 2023 | businesswire.comAthersys Licenses its Animal Health Assets to Ardent Animal HealthOctober 2, 2023 | finance.yahoo.comAthersys Director Jane Wasman Appointed Board ChairSeptember 26, 2023 | finance.yahoo.comAthersys Slumps as MultiStem Fails in Mid-Stage Study - Analyst BlogSeptember 6, 2023 | finance.yahoo.comGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationAugust 25, 2023 | finance.yahoo.comIs Athersys Inc (ATHX) Significantly Overvalued?August 18, 2023 | marketwatch.comAthersys Shares Tumble 26% After Pricing Public OfferingAugust 18, 2023 | investorplace.comWhy Is Athersys (ATHX) Stock Down 36% Today?August 18, 2023 | seekingalpha.comAthersys shares slide on pricing $3.5 million stock offeringAugust 18, 2023 | finance.yahoo.comAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingAugust 16, 2023 | finance.yahoo.comAthersys Reports Second Quarter 2023 Financial Results and Business HighlightsAugust 11, 2023 | finance.yahoo.comAthersys Appoints Neema Mayhugh, PhD to its Board of DirectorsAugust 11, 2023 | bizjournals.comAthersys executives foresee catalysts that could ease its financial journeyJuly 31, 2023 | businesswire.comAthersys to Host Business Update Conference Call on August 9thJuly 30, 2023 | fool.comAthersys (NASDAQ: ATHX)June 1, 2023 | tmcnet.comPatient Enrollment Begins in Third and Final CohortJune 1, 2023 | finance.yahoo.comPatient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic TraumaMay 23, 2023 | msn.comAthersys restructures debt with supplier, prioritizing multi-stem for stroke treatmentMay 23, 2023 | finance.yahoo.comAthersys Restructures Debt with SupplierMay 18, 2023 | bizjournals.comAthersys cuts quarterly loss as restructuring takes holdMay 18, 2023 | finance.yahoo.comAthersys Reports First Quarter 2023 Financial Results and Business HighlightsMay 8, 2023 | finance.yahoo.comAthersys to Participate in Three Upcoming ConferencesMay 1, 2023 | finance.yahoo.comAthersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care ConferenceApril 21, 2023 | finance.yahoo.comAthersys to Participate in The American Society for Neural Therapy and Repair Annual ConferenceApril 19, 2023 | finance.yahoo.comAthersys, Inc. Announces Closing of $3.7 Million Registered Direct Offering and Concurrent Private PlacementApril 18, 2023 | finance.yahoo.comAthersys, Inc. Announces $3.7 Million Registered Direct Offering and Concurrent Private PlacementApril 12, 2023 | businesswire.comAthersys to Host Business Update Conference Call on April 20 thApril 10, 2023 | finance.yahoo.comAthersys to Host Business Update Conference Call on April 20thMarch 31, 2023 | finance.yahoo.comAthersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 31, 2023 | finance.yahoo.comAthersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 22, 2023 | finance.yahoo.comAthersys Announces Successful Type B Meeting with the FDAFebruary 14, 2023 | finance.yahoo.comAthersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol DiscussionFebruary 2, 2023 | finance.yahoo.comAthersys to Host Business Update Conference Call on February 14thJanuary 30, 2023 | finance.yahoo.comAthersys to Participate in International Stroke Conference and BioProcess InternationalJanuary 11, 2023 | finance.yahoo.comAthersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in JanuaryJanuary 9, 2023 | finance.yahoo.comAthersys Provides MultiStem Clinical UpdateJanuary 4, 2023 | thestreet.comAthersys (ATHX) Stock Plummets to 52-Week Low as Stroke Therapy Fails Mid-Stage TrialJanuary 2, 2023 | thestreet.comHere’s Why Athersys (ATHX) Stock is Jumping Today Get Athersys News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter. Email Address Musk’s new company could top a trillion? (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. ATHX Media Mentions By Week ATHX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATHX News Sentiment▼0.230.62▲Average Medical News Sentiment ATHX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATHX Articles This Week▼10▲ATHX Articles Average Week Get Athersys News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: China SXT Pharmaceuticals News Today SciSparc News Today eFFECTOR Therapeutics News Today Ampio Pharmaceuticals News Today Lucy Scientific Discovery News Today Statera Biopharma News Today Evelo Biosciences News Today Grifols News Today LAVA Therapeutics News Today Mainz Biomed News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATHX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athersys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athersys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHX Stock Alerts